MEGHAN POLLARD: Open Payments
NPI 1790338531 · NEWPORT NEWS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$359 in 9 payments from 6 companies in 2025. Trend: 2023 $521 · 2024 $936 · 2025 $359
Food & beverage: $359
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $218 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| Eisai Inc. | 1 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Amgen Inc. | 1 | $18 |
| Antares Pharma, Inc. | 1 | $15 |
Products named: MOUNJARO, ZEPBOUND, TRELEGY ELLIPTA, Leqembi, REXULTI, AREXVY, OTEZLA, XYOSTED.
Industry payments across VA — which companies pay providers there.
